Ptprb-flox Mouse
Common Name
Ptprb-flox
제품 ID
S-CKO-18834
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-19263-Ptprb-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Ptprb-flox Mouse (카탈로그 번호 S-CKO-18834)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Ptprb-flox
품종 계통계통 ID
CKOCMP-19263-Ptprb-B6J-VB
유전자명
제품 ID
S-CKO-18834
유전자 별칭
Ptpz, Rptpb, Veptp, VE-PTP, C130094E24, 3230402H02Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 10
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000092167
NCBI 전사체 ID
NM_029928
타겟 영역
Exon 1~2
유효 영역 크기
~2.7 kb
유전자 연구 개요
Ptprb, also known as protein tyrosine phosphatase receptor type B or vascular endothelial protein tyrosine phosphatase (VE-PTP), is a transmembrane protein tyrosine phosphatase. It is involved in multiple biological processes, acting as a negative regulator of vascular growth factor tyrosine kinases [3]. It is also associated with pathways such as the angiopoietin-Tie2 signaling pathway [6]. Ptprb is important in angiogenesis, blood vessel remodelling, and branching morphogenesis [3,5]. Genetic models, like KO/CKO mouse models, can be valuable for studying its functions.
In the context of diseases, in pulmonary fibrosis, the expression level of PTPRB is reduced in both patients and mouse models. Forsythoside A can ameliorate pulmonary fibrosis by inhibiting lung fibroblast proliferation and endothelial-to-mesenchymal transition, and this effect may be related to PTPRB [1]. In colorectal carcinoma, PTPRB promotes metastasis via inducing epithelial-mesenchymal transition. Knockdown of PTPRB decreased the invasive ability of CRC cells in vitro and tumor metastasis in vivo [2]. In angiosarcoma, PTPRB harbored predominantly truncating mutations in some tumors, highlighting its potential role in this malignancy [3]. A rare homozygous variant in PTPRB was associated with human hypoplastic left heart syndrome, and in silico and splicing assays indicated potential pathogenic mechanisms [4]. In NSCLC, overexpression of PTPRB reduced cell proliferation, colony formation, soft agar growth, and cell invasion, while knockdown increased Src phosphorylation and cell invasion [7]. In brown adipocyte differentiation, PTPRB functions as a negative regulator by suppressing the tyrosine phosphorylation of VEGFR2 [8].
In conclusion, Ptprb is a crucial regulator in various biological processes. Studies using KO/CKO mouse models and other loss-of-function experiments have revealed its significance in diseases such as pulmonary fibrosis, colorectal carcinoma, angiosarcoma, hypoplastic left heart syndrome, NSCLC, and in the regulation of brown adipocyte differentiation. Understanding Ptprb's functions provides insights into disease mechanisms and potential therapeutic targets.
References:
1. Zhang, Qinqin, Zhang, Beibei, Yang, Fan, Wang, Mengya, Chen, Suiqing. 2024. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 130, 155715. doi:10.1016/j.phymed.2024.155715. https://pubmed.ncbi.nlm.nih.gov/38788399/
2. Weng, Xingyue, Chen, Wei, Hu, Wangxiong, Ye, Chenyang, Zheng, Shu. 2019. PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition. In Cell death & disease, 10, 352. doi:10.1038/s41419-019-1554-9. https://pubmed.ncbi.nlm.nih.gov/31040266/
3. Behjati, Sam, Tarpey, Patrick S, Sheldon, Helen, Harris, Adrian, Campbell, Peter J. 2014. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. In Nature genetics, 46, 376-379. doi:10.1038/ng.2921. https://pubmed.ncbi.nlm.nih.gov/24633157/
4. Jia, Yangying, Chen, Jianhai, Zhong, Jie, Ke, Bin, Li, Chunyu. 2022. Novel rare mutation in a conserved site of PTPRB causes human hypoplastic left heart syndrome. In Clinical genetics, 103, 79-86. doi:10.1111/cge.14234. https://pubmed.ncbi.nlm.nih.gov/36148623/
5. Soady, Kelly J, Tornillo, Giusy, Kendrick, Howard, Isacke, Clare M, Smalley, Matthew J. 2017. The receptor protein tyrosine phosphatase PTPRB negatively regulates FGF2-dependent branching morphogenesis. In Development (Cambridge, England), 144, 3777-3788. doi:10.1242/dev.149120. https://pubmed.ncbi.nlm.nih.gov/28870991/
6. Li, Yanyang, Liu, Pan, Zhou, Yalu, Jin, Jing, Quaggin, Susan E. 2023. Activation of Angiopoietin-Tie2 Signaling Protects the Kidney from Ischemic Injury by Modulation of Endothelial-Specific Pathways. In Journal of the American Society of Nephrology : JASN, 34, 969-987. doi:10.1681/ASN.0000000000000098. https://pubmed.ncbi.nlm.nih.gov/36787763/
7. Qi, Yinliang, Dai, Yuanchang, Gui, Shuyu. . Protein tyrosine phosphatase PTPRB regulates Src phosphorylation and tumour progression in NSCLC. In Clinical and experimental pharmacology & physiology, 43, 1004-12. doi:10.1111/1440-1681.12610. https://pubmed.ncbi.nlm.nih.gov/27314562/
8. Kim, Ji Soo, Kim, Won Kon, Oh, Kyoung-Jin, Lee, Sang Chul, Bae, Kwang-Hee. . Protein Tyrosine Phosphatase, Receptor Type B (PTPRB) Inhibits Brown Adipocyte Differentiation through Regulation of VEGFR2 Phosphorylation. In Journal of microbiology and biotechnology, 29, 645-650. doi:10.4014/jmb.1810.10033. https://pubmed.ncbi.nlm.nih.gov/30845793/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
